Presented By: Strafford, A BARBRI Company
About the Course
White bagging mandates continue to reshape how providers access and administer in-office medications, raising complex reimbursement, compliance, and litigation concerns for healthcare systems, physician practices, and pharmacies.
Frier Levitt partner Jesse Dresser will serve as a presenter in an upcoming CLE webinar examining emerging trends in white bagging and how providers are responding to payer-imposed mandates.
White bagging occurs when insurers require that provider-administered medications be dispensed exclusively through payer-owned or affiliated specialty pharmacies and shipped directly to the provider for administration. While payers often justify these mandates as cost-containment measures, providers have raised significant concerns regarding patient safety, supply chain integrity, reimbursement disruption, contract interference, and 340B program participation.
Learning Objectives
During this program, the panel will address:
- Litigation strategies and how courts are analyzing white bagging disputes
- Reimbursement implications and contract negotiation considerations
- Regulatory compliance risks associated with payer-mandated sourcing
- The impact of white bagging on 340B participation
- Practical mitigation strategies healthcare providers are deploying
Attendees will gain a clearer understanding of the legal and operational risks associated with mandatory white bagging policies, as well as strategic tools to evaluate payer contracts, preserve reimbursement, and protect patient care standards.
For healthcare counsel, in-house legal teams, compliance officers, and provider executives navigating evolving payer practices, this program offers timely insight into one of the most pressing reimbursement and regulatory developments affecting provider-administered drugs.
